Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice
Open Access
- 1 January 2017
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 25 (1) , 165-180
Abstract
No abstract availableKeywords
Funding Information
- Else Kröner-Fresenius Foundation
- Else Kröner-Fresenius Memorial scholarship
This publication has 45 references indexed in Scilit:
- Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1Nature Medicine, 2013
- Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in miceKidney International, 2012
- Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic PathwaysScience Translational Medicine, 2012
- Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal FibrosisJournal of the American Society of Nephrology, 2012
- Smad3-Mediated Upregulation of miR-21 Promotes Renal FibrosisJournal of the American Society of Nephrology, 2011
- MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in DiabetesJournal of Biological Chemistry, 2011
- Silencing of microRNA families by seed-targeting tiny LNAsNature Genetics, 2011
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer CellsCancer Research, 2009
- MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressorsProceedings of the National Academy of Sciences, 2007